These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9593593

  • 1. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.
    Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE.
    Eur J Pharmacol; 1998 Mar 12; 345(1):47-53. PubMed ID: 9593593
    [Abstract] [Full Text] [Related]

  • 2. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE, Hammond DL.
    J Pharmacol Exp Ther; 1993 Aug 12; 266(2):820-8. PubMed ID: 8394918
    [Abstract] [Full Text] [Related]

  • 3. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA, Mosberg HI, Porreca F.
    Life Sci; 1990 Aug 12; 47(11):PL43-7. PubMed ID: 2170791
    [Abstract] [Full Text] [Related]

  • 4. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.
    Eur J Pharmacol; 1994 Feb 03; 252(2):133-7. PubMed ID: 8157053
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD, Porreca F.
    J Pharmacol Exp Ther; 1992 Feb 03; 260(2):518-25. PubMed ID: 1310737
    [Abstract] [Full Text] [Related]

  • 8. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ, Bian JT, Bhargava HN.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):161-6. PubMed ID: 9369369
    [Abstract] [Full Text] [Related]

  • 9. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH, Kovelowski CJ, Nichols ML, Hruby VJ, Porreca F.
    Pain; 1995 Sep 24; 62(3):287-293. PubMed ID: 8657428
    [Abstract] [Full Text] [Related]

  • 10. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
    Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T, Nagase H.
    Life Sci; 1995 Sep 24; 57(2):155-68. PubMed ID: 7603296
    [Abstract] [Full Text] [Related]

  • 11. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 24; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 12. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F.
    Eur J Pharmacol; 1989 Oct 04; 169(1):43-52. PubMed ID: 2557223
    [Abstract] [Full Text] [Related]

  • 13. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL, Stewart PE, Littell L.
    J Pharmacol Exp Ther; 1995 Sep 04; 274(3):1317-24. PubMed ID: 7562504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.
    Hurley RW, Grabow TS, Tallarida RJ, Hammond DL.
    J Pharmacol Exp Ther; 1999 May 04; 289(2):993-9. PubMed ID: 10215679
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.
    Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T.
    Pharmacol Biochem Behav; 1995 May 04; 51(2-3):535-9. PubMed ID: 7667382
    [Abstract] [Full Text] [Related]

  • 19. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 04; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.